Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 271 AL 285

Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy

Olazarán J, Reisberg B, Clare L, Cruz I, Peña-Casanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C, Spector A, Fazio S, Bond J, Kivipelto M, Brodaty H, Rojo JM, Collins H, Teri L, Mittelman M, Orrell M, Feldman HH, Muñiz R.

Dement Geriatr Cogn Disord. 2010;30(2):161-78. doi: 10.1159/000316119. Epub 2010 Sep 10.

Why is the New York Times writing so much about Alzheimer's disease therapies?

Bartfai T.

ScientificWorldJournal. 2010 Sep 14;10:1886-9. doi: 10.1100/tsw.2010.185.

Naltrexone effects in patients with dementia

Read SL.

Am J Psychiatry. 2010 Oct;167(10):1278-9. doi: 10.1176/appi.ajp.2010.09111630.

Exercise rehabilitation on home-dwelling patients with Alzheimer's disease--a randomized, controlled trial. Study protocol

Pitkala KH, Raivio MM, Laakkonen ML, Tilvis RS, Kautiainen H, Strandberg TE.

Trials. 2010 Oct 6;11:92. doi: 10.1186/1745-6215-11-92.

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

Tzimopoulou S, Cunningham VJ, Nichols TE, Searle G, Bird NP, Mistry P, Dixon IJ, Hallett WA, Whitcher B, Brown AP, Zvartau-Hind M, Lotay N, Lai RY, Castiglia M, Jeter B, Matthews JC, Chen K, Bandy D, Reiman EM, Gold M, Rabiner EA, Matthews PM.

J Alzheimers Dis. 2010;22(4):1241-56. doi: 10.3233/JAD-2010-100939.

Modern care for patients with Alzheimer disease: rationale for early intervention

Galluzzi KE, Appelt DM, Balin BJ.

J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S37-42.

Mindfulness effects on caregiver stress: should we expect more?

Khalsa DS.

J Altern Complement Med. 2010 Oct;16(10):1025-6. doi: 10.1089/acm.2010.0431.

Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results

Yaffe K.

JAMA. 2010 Nov 3;304(17):1952-3. doi: 10.1001/jama.2010.1625.

Needs in early onset dementia: A qualitative case from the NeedYD study

Bakker C, de Vugt ME, Vernooij-Dassen M, van Vliet D, Verhey FR, Koopmans RT.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):634-40. doi: 10.1177/1533317510385811.

The singer or the singing: who sings individually to persons with dementia and what are the effects?

Chatterton W, Baker F, Morgan K.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):641-9. doi: 10.1177/1533317510385807.

Comparing responses to horticultural-based and traditional activities in dementia care programs

Jarrott SE, Gigliotti CM.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):657-65. doi: 10.1177/1533317510385810.

Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin

Hamuro A, Saito S.

Psychogeriatrics. 2010 Dec;10(4):198-200. doi: 10.1111/j.1479-8301.2010.00338.x.

Overview of non-pharmacological intervention for dementia and principles of brain-activating rehabilitation

Yamaguchi H, Maki Y, Yamagami T.

Psychogeriatrics. 2010 Dec;10(4):206-13. doi: 10.1111/j.1479-8301.2010.00323.x. Epub 2010 Aug 28.

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)

Olin JT, Bhatnagar V, Reyes P, Koumaras B, Meng X, Brannan S.

Int J Geriatr Psychiatry. 2010 Apr;25(4):419-26. doi: 10.1002/gps.2355.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias